Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures FTSE +0.03%, DAX (0.14%), CAC40 +0.23%

May 28 ,2025

  • Synopsis

    • European equity markets are set for a mixed open amidst mixed Asian equities Wednesday. Hang Seng leading China market declines with semis under pressure. Korea outperforming amid rally in tech stocks. Japan, Australia and Taiwan also higher. S&P 500 futures flat afterhours.

    • In central banks, Austria central bank and SUERF Annual Economics Conf 'Monetary policy: taking a walk on the supply side' speakers include governor Holzmann, ECB's Acre and BOE's Pill. Riksbank releases its latest Financial Stability Report at 9:30CET, related press conf. (livestream) at 11:00. Denmark central bank's Nødgaard speech at 13:00CET at event hosted by JP/Politikens Hus. ECB releases at 10:00CET the results of latest consumer inflation expectations survey. In US, after the European market close, FOMC releases minutes of last meeting. OPEC Joint Ministerial Monitoring Committee meeting scheduled.

    • Macro data due include Germany May unemployment change, France Q1 final GDP, Apr consumer goods spending, PPI, Switzerland Apr economic sentiment index, Norway Apr retail sales, Sweden Apr retail sales, trade balance, Denmark Apr unemployment rate, Belgium Q1 final GDP, May CPI, Netherlands Apr PPI, Ireland Apr retail sales.

    • In earning, Aroundtown (AT1.GR) reported Q1 FFO €0.07 vs FactSet €0.08 whilst SOITEC (SOI.FP) reported FY net income €92M vs FactSet €103.5M and quides Q1 revenue to be down ~20% y/y. Elekta (EKTA.B.SS) released Q4 EPS SEK1.11 ex-items vs consensus SEK1.38.

    • In other corporate news, Rémy Cointreau (RCO.FP) appointed Franck Marilly as new CEO.

    • Amongst CMDs and other investor events are Orkla (ORK.NO), Soitec (SOI.FP), Grenergy Renovables (GRE.SM), AstraZeneca (AZN.LN) sustainability 2024 highlights call.

  • Top company news

    • Earnings/updates

      • DACHs:

        • VVV3.GR Ökoworld reports FY EPS €3.85 vs year-ago €3.09

        • PSG.GR PharmaSGP Holding reports Q1 EPS €0.41 vs year-ago €0.38

        • 9Q9.GR (Azerion Group) -- reports Q1 adjusted EBITDA €11.7M vs year-ago €9.8M; FY25 guidance unchanged

        • BNN.GR (BRAIN Biotech) -- reports Q2 adjusted EBITDA (€1.1M) vs year-ago (€0.5M)

        • AT1.GR (Aroundtown) -- reports Q1 FFO €0.07 vs FactSet €0.08

        • B8FK.GR (Biofrontera AG) -- withdraws prior outlook; discloses payment difficulties

        • DESN.SW (Dottikon ES Holding) -- reports FY net income CHF105.6M vs FactSet CHF70.3M [1 est]

      • France:

        • SOI.FP (SOITEC) -- reports FY net income €92M vs FactSet €103.5M [17 est, €81.4-117.0M]; quides Q1 revenue to be down ~20% y/y

        • ELIS.FP (Elis) -- releases presentation material in connection with its CMD

        • GNRO.FP (GeNeuro) -- SA announces definitive Debt-Restructuring Moratorium

      • Nordics:

        • EKTA.B.SS (Elekta) -- reports Q4 EPS SEK1.11 ex-items vs consensus SEK1.38

        • SAAB.B.SS (Saab) -- releases presentation material in connection with its CMD

        • PAAL.B.DC (Per Aarsleff Holding) -- reports final H1 earnings in line with prelim. release, EPS DKK18.17; reaffirms FY guidance

        • ORK.NO (Orkla) -- Jotun reports H1 operating profit NOK2.44B vs year-ago NOK2.39B

        • RAIVV.FH (Raisio) -- strategy 2025-27; releases presentation material in connection with its CMD

        • NYKD.NO (Nykode Therapeutics) -- reports Q1 net income ($1.4M) vs year-ago ($14.9M)

        • VOW.NO (Vow) -- reports Q1 pretax income (NOK30.4M) vs year-ago (NOK17.0M)

        • PLSV.NO (Paratus Energy Services) -- reports Q1 net income $3.2M vs FactSet $2.4M [5 est, ($13)-20M]

    • M&A

      • 7201.JP (Nissan Motor) -- seeking to raise more than ¥1T ($7B) in debt and asset sales - Bloomberg

      • ARION.IR (Arion Banki) -- proposes merger talks with Kvika Banki

      • AI.FP (Air Liquide) -- announces two acquisition in Germany; terms not disclosed

      • SAB.SM (Banco de Sabadell) -- BBVA notes decision of Spanish Minister of Economy in connection with offer for Banco de Sabadell

      • LLC.AU (Lendlease Group) -- Barings, GIC, and AustralianSuper among groups considering bids for Keyton - The Australian

      • WIHN.SW (WISeKey International Holding) -- SEALSQ Corp - a member of the WISeKey Group - signs share purchase agreement to acquire 100% of IC'ALPS; price not disclosed

      • GIMB.BB (Gimv) -- sells Joolz to Bugaboo

      • AUB.FP (Aubay) -- enters into exclusive negotiations with Holding Solutec SAS to acquire 100% of Solutec's share capital

      • Sev.en Global Investments acquires $40M in Coronado Global Resource debt -The Australian

      • Nippon Steel expected to close acquisition of US Steel for $55/sh:

    • Healthcare

      • POXEL.FP (Poxel) -- to present new clinical and scientific Data on TWYMEEG at the 68th Annual Meeting of the Japan Diabetes Society

      • ROG.SW (Roche Holding) -- Roche releases presentation material in connection with its Diagnostics Day

      • GALD.SW (Galderma Group) -- Galderma intends to buyback ~2.4M shares in the context of the accelerated bookbuild offering by EQT, ADIA and Auba

      • CRNA.NO (Circio Holding) -- Circio to present new and differentiating circVec data and corporate update in live webcast at 10:00 CET today

      • IRLAB.A.SS (IRLAB Therapeutics) -- IRLAB reports positive results from the second part of a Phase I study with IRL757 for the treatment of apathy

    • Other

      • EUROB.GA (Eurobank Ergasias Services & Holdings) -- holder Fairfax Financial Holdings intends to participate Eurobank's share buyback

      • FFARM.NA (ForFarmers) -- secures new €150M credit facility

      • RCO.FP (Rémy Cointreau) -- appoints Franck Marilly as new CEO

      • GALD.SW (Galderma Group) -- repurchases ~2.4M shares at CHF97.75/share for a total consideration of CHF232.5M

      • KNIN.SW (Kuehne & Nagel) -- and Natilus announce a strategic partnership to study economic and sustainability benefits in commercial air freight

      • TKA.GR (ThyssenKrupp) -- CEO defends strategic alignment; says it is not a job cutting program - FAZ

      • EQT.SS (EQT AB) -- resolves on repurchase of ordinary share

      • SBMO.NA (SBM Offshore) -- announces FPSO Alexandre de Gusmão producing and on hire

      • ARCAD.NA (ARCADIS) -- selected to provide services for $2.3B Calcasieu Bridge Project in US

      • SOI.FP (SOITEC) -- CFO Léa Alzingre steps down; appoints Albin Jacquemont as new CFO

      • ALPHA.GA (Alpha Services & Holdings) -- Alpha Services and Holdings signs MoU with ELTA for a strategic partnership to provide financial services across Greece

      • Australia gives preliminary approval to extend North West Shelf LNG's operating life to 2070, with conditions - Bloomberg

      • Bega Cheese notes Fonterra seeking leave to appeal NSW Supreme Court ruling in trademark dispute

  • Key rating changes

    • Upgrades

      • Kepler Cheuvreux upgrades AED.BB; downgrades LI.FP

      • KOJAMO.FH (Kojamo) -- buy from hold at Kepler Cheuvreux

      • EUROB.GA (Eurobank Ergasias Services & Holdings) -- to overweight from equal-weight at Morgan Stanley

    • Downgrades

      • SBB.B.SS (Samhällsbyggnadsbolaget i Norden) -- reduce from hold at Kepler Cheuvreux

      • NG.LN (National Grid) -- to sector perform from outperform at RBC Capital Markets

      • BOL.SS (Boliden) -- to hold from buy at Handelsbanken

  • Data

    • Nikkei +0.26% to 37822.32

    • Hang Seng (0.62%) to 23236.65

    • Shanghai Composite +0.03% to 3341.52

    • S&P futures (3.0) vs prior close of 5934.3

    • €-$ (0.0017) or (0.15%) to 1.1312

    • $-¥ (0.05) or (0.03%) to 144.31

    • €-¥ (0.29) or (0.18%) to 163.23

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE